Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Imane Bouchachia"'
Autor:
M Ryazantseva, Pamela Maher, Axel Methner, E Kaznacheyeva, Imane Bouchachia, Nadine Henke, Philipp Albrecht, K Knoll, Jan Lewerenz
Publikováno v:
Cell Death & Disease
Europe PubMed Central
Europe PubMed Central
The mouse hippocampal cell line HT22 is an excellent model for studying the consequences of endogenous oxidative stress. Addition of extracellular glutamate depletes the cells of glutathione (GSH) by blocking the glutamate-cystine antiporter system x
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a9f3d2400879507ac562373adbfdf8
https://pubmed.ncbi.nlm.nih.gov/23348584
https://pubmed.ncbi.nlm.nih.gov/23348584
Autor:
Jan Lewerenz, Axel Methner, Philipp Albrecht, Andrea Issberner, Pamela Maher, Nadine Henke, Imane Bouchachia, Mai-Ly Tran Tien
Publikováno v:
Neurochemistry international. 62(5)
Cell death in response to oxidative stress plays a role in a variety of neurodegenerative diseases and can be studied in detail in the neuronal cell line HT22, where extracellular glutamate causes glutathione depletion by inhibition of the glutamate/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b338ca50db1613a329c44dbd44be10b
https://pubmed.ncbi.nlm.nih.gov/23357478
https://pubmed.ncbi.nlm.nih.gov/23357478
Autor:
Imane Bouchachia, Philipp Albrecht, Harald H. Hofstetter, Zsuzsa Kovacs, Nadine Henke, Axel Methner, Corinna Zimmermann, Hans Hartung
Publikováno v:
Neurology. 78:P02.120-P02.120
Objective: To evaluate the mechanism of action of dimethylfumarate (DMF), a novel oral therapeutic for the treatment of multiple sclerosis. Background An oral formulation of DMF (BG00012) proved to be effective in patients with relapsing-remitting mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2853dc3d7a1e9a06e27fb2f579960d80
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p02.120
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p02.120
Publikováno v:
Neurology. 78:P02.110-P02.110
Objective: To evaluate the antioxidant potential of Laquinimod, a novel oral therapeutic for the treatment of Multiple Sclerosis (MS). Background MS is an inflammatory autoimmune disorder, where chronic disability is due to axonal and neuronal degene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5568e4c9f28ffd12e2cbcf647d65f81
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p02.110
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p02.110
Autor:
Axel Methner, Norbert Goebels, Kim Quasthoff, Jan Lewerenz, Zsuzsa Kovacs, Philipp Albrecht, Hans-Peter Hartung, Anne-Kathrin Mausberg, Pamela Maher, Nadine Henke, Andrea Issberner, Harald H. Hofstetter, Imane Bouchachia, Dmitrij Lisak, Corinna Zimmermann
Publikováno v:
Europe PubMed Central
Journal of Neuroinflammation, Vol 9, Iss 1, p 163 (2012)
Journal of Neuroinflammation
Journal of Neuroinflammation, Vol 9, Iss 1, p 163 (2012)
Journal of Neuroinflammation
Background Neuronal degeneration in multiple sclerosis has been linked to oxidative stress. Dimethyl fumarate is a promising novel oral therapeutic option shown to reduce disease activity and progression in patients with relapsing-remitting multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29d027a3db5c384a48628c4637574c69
http://europepmc.org/abstract/med/22769044
http://europepmc.org/abstract/med/22769044
